Skip to main content
. 2022 Sep 6;479(17):1807–1824. doi: 10.1042/BCJ20210851

Figure 7. Carbidopa-mediated suppression of IDO1 in tumor cells inhibits mTORC1 signaling pathway.

Figure 7.

(A and B) Western blotting showing protein expression of S6K and 4EBP1 (total and phospho-form) in carbidopa-treated BxPC-3 and HPAF-II cell lines, which were also treated with MG132 to rule out protein degradation. β-actin was used as an endogenous control.